Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo. (2021)
Attributed to:
Engineering Multi-functional Nanomaterials to Treat Metastatic Cancer
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2020.12.017
PubMed Identifier: 33333118
Publication URI: http://europepmc.org/abstract/MED/33333118
Type: Journal Article/Review
Volume: 330
Parent Publication: Journal of controlled release : official journal of the Controlled Release Society
ISSN: 0168-3659